Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

In the year 2025, Castle Biosciences had annual revenue of $344.23M with 3.66% growth. Castle Biosciences had revenue of $87.01M in the quarter ending December 31, 2025, with 0.81% growth.

• Revenue (ttm): $344.23M
• Revenue Growth: +3.66%
• P/S Ratio: 2.16
• Revenue / Employee: $389,840
• Employees: 883
• Market Cap: 744.07M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	344.23M	12.16M	3.66%
Dec 31, 2024	332.07M	112.28M	51.09%
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%
Dec 31, 2019	51.87M	29.08M	127.62%
Dec 31, 2018	22.79M	9.03M	65.67%
Dec 31, 2017	13.75M	-	-